The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat

Neuropsychopharmacology

Volumn 30, Issue 6, 2005, Pages 1104-1110

  Bachteler, Daniel ^a   Economidou, Daina ^b   Danysz, Wojciech ^c   Ciccocioppo, Roberto ^b   Spanagel, Rainer ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF CAMERINO   (Italy)

^c MERZ PHARMACEUTICALS GMBH   (Germany)

Author keywords

Acamprosate; Craving; Cue induced reinstatement; Neramexane; Relapse

Indexed keywords

ACAMPROSATE; ALCOHOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERAMEXANE;

ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANISE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; ODOR; OLFACTORY DISCRIMINATION; ORANGE (FRUIT); PRIORITY JOURNAL; RAT; RELAPSE; STIMULUS; WATER AVAILABILITY; WHITE NOISE;

ALCOHOL DETERRENTS; ALCOHOL DRINKING; ANIMALS; CONDITIONING, OPERANT; CUES; CYCLOPENTANES; EXTINCTION, PSYCHOLOGICAL; INJECTIONS, INTRAPERITONEAL; MALE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; RECURRENCE; TAURINE;

EID: 16844382736     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300657     Document Type: Article

References (55)

1. 2+ channels in cultured rat mesencephalic neurons. Naunyn-Schmiedeberg's Arch Pharmacol 362: 440-443.
2. Al-Qatari M, Bouchenafa O, Littleton J (1998). Mechanism of action of acamprosate: Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex. Alcohol Clin Exp Res 22: 810-814.
3. Bäckström P, Bachteler D, Koch S, Hyytiä P, Spanagel R (2004). mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacology 29: 921-928.
4. Bäckström P, Hyytiä P (2004). Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behavior. Alcoholism Clin Exp Res 28: 558-565.
5. Bienkowski P, Koros E, Kostowski W, Danysz W (1999). Effects of N-methyl-D-aspartate receptor antagonists on reinforced and non-reinforced responding for ethanol in rats. Alcohol 18: 131-137.
6. Cano-Cebrian MJ, Zornoza-Sabina T, Guerri C, Polache A, Granero L (2003). Local acamprosate modulates dopamine release in the rat nucleus accumbens through NMDA receptors: an in vivo microdialysis study. Naunyn-Schmiedeberg's Arch Pharmacol 367: 119-125.
7. Ciccocioppo R, Angeletti S, Weiss F (2001). Long-lasting resistance to extinction of response reinstatement induced by ethanol-related stimuli: role of genetic ethanol preference. Alcohol Clin Exp Res 25: 1414-1419.
8. Ciccocioppo R, Lin D, Martin-Fardon R, Weiss F (2003). Reinstatement of ethanol-seeking behavior by drug cues following single versus multiple ethanol intoxication in the rat: effects of naltrexone. Psychopharmacology 168: 208-215.
9. 1 or δ opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology 27: 391-399.
10. Cole JC, Littleton JM, Little HJ (2000). Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus-maze. Psychopharmacology 147: 403-411.
11. Dahchour A, De Witte P (2000). Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate. Prog Neurobiol 60: 343-362.
12. Dahchour A, De Witte P (2003). Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods. Alcohol Clin Ex Res 27: 465-470.
13. De Witte P, Pinto E, Ansseau M, Verbanck P (2003). Alcohol and withdrawal: from animal research to clinical issues. Neurosci Biobehav Rev 27: 189-197.
14. Everitt BJ, Dickinson A, Robbins TW (2001). The neuropsychological basis of addictive behaviour. Brain Res Brain Res Rev 36: 129-138.
15. Harris BR, Gibson DA, Prendergast MA, Blanchard JA, Holley RC, Hart SR et al (2003). The neurotoxicity induced by ethanol withdrawal in mature organotypic hippocampal slices might involve cross-talk between metabotropic glutamate type 5 receptors and N-methyl-D-aspartate receptors. Alcohol Clin Exp Res 27: 1724-1735.
16. Harris BR, Prendergast MA, Gibson DA, Rogers DT, Blanchard JA, Holley RC et al (2002). Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors. Alcohol Clin Exp Res 26: 1779-1793.
17. Heyser CJ, Moc K, Koob GF (2003). Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats. Neuropsychopharmacology 28: 1463-1471.
18. Heyser CJ, Schulteis G, Durbin P, Koob GF (1998). Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18: 125-133.
19. Hölter SM, Danysz W, Spanagel R (1996). Evidence for alcohol anti-craving properties of memantine. Eur J Pharmacol 314: 1-2.
20. Hölter SM, Danysz W, Spanagel R (2000). Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure. J Pharmacol Exp Ther 292: 545-552.
21. Hölter SM, Landgraf R, Zieglgänsberger W, Spanagel R (1997). Time course of acamprosate action on operant self-administration after ethanol deprivation. Alcohol Clin Exp Res 21: 862-868.
22. Katner SN, Magalong JG, Weiss F (1999). Reinstatement of alcohol-seeking behavior by drug associated discriminative stimuli after prolonged extinction in the rat. Neuropsychopharmacology 20: 471-479.
23. Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R et al (2003). Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 60: 92-99.
24. Littleton J (1995). Acamprosate in alcohol dependence: how does it work? Addiction 90: 1179-1188.
25. Liu X, Weiss F (2002). Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent rats. J Pharmacol Exp Ther 300: 882-889.
26. Ludwig AM, Wikler A, Stark LH (1974). The first drink. Psychobiological aspects of craving. Arch Gen Psychiatry 30: 539-547.
27. Mason BJ, Goodman AM, Dixon RM, Abdel Hameed MH, Hulot T, Wesnes K et al (2002). A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone. Neuropsychopharmacology 27: 596-606.
28. McCusker CG, Brown K (1990). Alcohol-predictive cues enhance tolerance to and precipitate 'craving' for alcohol in social drinkers. J Stud Alcohol 51: 494-499.
29. McCusker CG, Brown K (1991). The cue-responsivity phenomenon in dependent drinkers: 'personality' vulnerability and anxiety as intervening variables. Br J Addict 86: 905-912.
30. McGeehan AJ, Olive MF (2003). The anti-relapse compound acamprosate inhibits the development of a conditioned preference to ethanol and cocaine but not morphine. Br J Pharmacol 138: 9-12.
31. Monti PM, Rohsenow DJ, Hutchison KE (2000). Toward bridging the gap between biological, psychobiological and psychosocial models of alcohol craving. Addiction 95(Suppl): S229-S236 (review).
32. Monti PM, Rohsenow DJ, Hutchison KE, Swift RM, Mueller TI, Colby SM et al (1999). Naltrexone's effect on cue-elicited craving among alcoholics in treatment. Alcohol Clin Exp Res 23: 1386-1394.
33. Monti PM, Rohsenow DJ, Rubonis AV, Niaura RS, Sirota AD, Colby SM et al (1993). Alcohol cue reactivity: effects of detoxification and extended exposure. J Stud Alcohol 54: 235-245.
34. Naassila M, Hammoumi S, Legrand E, Durbin P, Daoust M (1998). Mechanism of action of acamprosate: Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain. Alcohol Clin Exp Res 22: 802-809.
35. Newlin DB (1987). Alcohol expectancy and conditioning in sons of alcoholics. Adv Alcohol Subst Abuse 6: 33-57.
36. O'Brien CP, Childress AR, Ehrman R, Robbins SJ (1998). Conditioning factors in drug abuse: can they explain compulsion? J Psychopharmacol 12: 15-22.
37. O'Brien CP, Volpicelli LA, Volpicelli JR. (1996). Naltrexone in the treatment of alcoholism: a clinical review. Alcohol 13: 35-39 (review).
38. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992). Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 49: 881-887.
39. Olive MF, Nannini MA, Ou CJ, Koenig HN, Hodge CW (2002). Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release. Eur J Pharmacol 437: 55-61.
40. Parsons CG, Danysz W, Quack G (2000). Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists - in vitro characterisation. Amino Acids 19: 157-166.
41. Piasecki J, Koros E, Dyr W, Kostowski W, Danysz W, Bienkowski P (1998). Ethanol-reinforced behavior in rats: effects of uncompetitive NMDA receptor antagonist, memantine. Eur J Pharmacol 354: 135-143.
42. Quertemont E, Brabant C, De Witte P (2002). Acamprosate reduces context-dependent effects. Psychopharmacology 164: 10-18.
43. Rammes G, Mahal B, Putzke J, Parsons C, Spielmanns P, Pestel E et al (2001). The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801. Neuropharmacology 40: 749-760.
44. Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB (2000). Naltrexone's effects on reactivity to alcohol cues among alcoholic men. J Abnorm Psychol 109: 738-742.
45. Samson HF (1986). Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-salted rats. Alcohol Clin Exp Res 10: 436-442.
46. Siggins GR, Martin G, Roberto M, Nie Z, Madamba S, De Lecea L (2003). Glutamatergic transmission in opiate and alcohol dependence. Ann N Y Acad Sci 1003: 196-211.
47. Spanagel R, Pendyala G, Abarca C, Zghoul T, Sanchis-Segura C, Magnone MC et al (2005). The circadian clock gene Period2 alters the glutamatergic system and thereby modulates alcohol consumption. Nat Med 11: 1-8.
48. Spanagel R, Weiss F (1999). The dopamine hypothesis of reward: past and current status. Trends Neurosci 22: 521-527.
49. Spanagel R, Zieglgänsberger W (1997). Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18: 54-59.
50. Staiger PK, White JM (1991). Cue reactivity on alcohol abusers: stimulus specificity and extinction of the response. Addict Behav 16: 211-221.
51. Tiffany ST, Conklin CA (2000). A cognitive processing model of alcohol craving and compulsive alcohol use. Addiction 95(Suppl): S145-S153 (review).
52. Tsai G, Coyle JT (1998). The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 49: 173-184.
53. Vengeliene V, Spanagel R (2004). The role of the NMDA receptor in alcohol relapse. Alcohol Clin Exp Res 28: 18A.
54. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992). Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49: 876-880.
55. Weiss F, Lorang MT, Bloom FE, Koob GF (1993). Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J Pharmacol Exp Ther 267: 250-258.